SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 25, 2003
Kewaunee Scientific Corporation
(Exact name of registrant as specified in its charter)
| Delaware | 0-5286 | 38-0715562 | ||
| (State or other jurisdiction of incorporation or organization) | (Commission File Number) | (IRS Employer Identification No.) |
2700 West Front Street
Statesville, NC 28677
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code:(704) 873-7202
N/A
(Former name or former address, if changed since last report)
| Item 7. Financial | Statements and Exhibits. |
| (c) | Exhibits. |
| Exhibit Number | Description of Exhibit | |
99.1 | Press Release, dated August 25, 2003, of Kewaunee Scientific Corporation, announcing its first quarter earnings. |
| Item 9. Regulation | FD Disclosure (Information is Being Provided Under Item 12). |
On August 25, 2003, Kewaunee Scientific Corporation (the “Company”) issued a Press Release announcing its first quarter earnings. The Press Release is incorporated herein by reference, and is included as Exhibit 99.1 to this Current Report on Form 8-K.
Exhibit 99.1 to this report contains information regarding a non-recurring gain incurred by the Company. For comparative purposes, following the disclosure of the Company’s net earnings in Exhibit 99.1 which includes the applicable non-recurring gain, the Company has reported the impact on net earnings resulting from the non-recurring gain, such additional information constituting a “non-GAAP financial measure” as defined in Item 10 of Regulation S-K of the Securities Exchange Act of 1934, as amended. The Company has included this additional information because it believes that the disclosure of such information is useful for comparing the Company’s results of operations to prior periods.
The information furnished under “Item 9. Regulation FD Disclosure” is intended to be furnished under “Item 12. Results of Operations and Financial Condition” in accordance with SEC Release No. 33-8216. The information in this Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Page - 1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 25, 2003
Kewaunee Scientific Corporation | ||
By: | /s/ D. Michael Parker | |
D. Michael Parker Senior Vice President, Finance and | ||
Page - 2